Integrated BioPharma entered 2004 on a sound financial footing with good earnings and a healthy balance sheet.

 
 

Net sales (FY 2003): $22,235,306

 
 

Earnings per share: $0.09 (on 10.4 million shares outstanding)

 
 

Total assets: $20.8 million

 
 

Total liabilities: $2.6 million

 
 

External debt: $ 0

 
 

Working capital ratio: 7:1

 
 
 
225 Long Avenue, Hillside, NJ 07205 USA
Tel 973.926.0816  Fax 973.926.1735
Investor Relations 888.319.6962